TRIAL natriuretic peptide (ANP), a new peptide with potent natriuretic activity, was isolated from human atrial tissue, sequenced and synthesized.1) Synthetic ANP causes natriuresis and diuresis and decreases blood pressure when infused into normal persons.1) It has been demonstrated2) that circulating ANP is elevated in proportion to the increase in right atrial pressure or pulmonary artery wedge pressure (PAWP) in patients with congestive heart failure, supporting the hypothesis3), 4) that atrial distension stimulates the release of the peptide.
On the other hand, several investigators5), 6) have observed that physical exercise raises the plasma level of ANP in healthy persons and cardiac patients.
It has been recognized7) that many patients with coronary artery disease have normal left ventricular systolic function at rest and develop abnormalities only during exercise. Radionuclide ventriculography performed with the patient at rest and during exercise is an established method of evaluating suspected coronary artery disease.7)-10) In the present study, we determined plasma levels of ANP at rest and during exercise in normal volunteers and patients with coronary artery disease. Ejection fraction was also measured by gated radionuclide ventriculography in an attempt to clarify the relationship between circulating ANP and cardiac function. sphygmomanometer cuff was placed on the arm that was not used for injection. After the patient was in the recumbent position for at least 1 hour, exercise was performed on a supine bicycle exercise table. It began at a work load of 25 watts and exercise loads were increased by 25 watt increments at 3min intervals, culminating in a load that produced symptoms of angina or dyspnea, or fatigue of sufficient severity to limit further exercise. Heart rate and blood pressure were recorded with the patients at rest and at maximal work load (immediately after ceasing the stress test). Heart rate and rhythm were recorded by ECG and blood pressure was measured by the standard cuff technique. 
DISCUSSION
Physiologic assessment of patients with stable coronary artery disease is inadequate when performed only with the patients at rest.7) In this state, myocardial oxygen supply and demand are in balance. However, during exercise, supply-demand imbalance and myocardial ischemia may occur which result in transient pathophysiologic abnormalities. Noninvasive evaluation of left ventricular performance during exercise has utilized the gated cardiac blood pool imaging technique. Many investigators7)-10) have used radionuclide angiography to measure left ventricular function during rest and exercise and have demonstrated the presence of impaired global and regional left ventricular reserve during exercise in patients with coronary artery disease.
The present study has shown that exercise increases the plasma level of ANP in both normal persons and patients with coronary artery disease. The patients had a greater response of plasma ANP than did the normal persons in relation to changes in heart rate, systolic blood pressure or ejection fraction, indicating an enhanced exercise-induced rise in plasma ANP in these patients. The physiologic basis for the release of ANP during exercise is important. A direct action of catecholamines is unlikely, because Katsube et al13) have reported that the response of ANP to vasoconstrictors like catecholamines is indirect and is brought about by elevation of right atrial pressure induced by these substances. On the other hand, the increase in heart rate might contribute to the rise in plasma ANP, since supraventricular tachycardia is accompanied by the increase in plasma ANP; however, Nicklas et al14) have shown that patients with sinus tachycardia have no significant increase in plasma ANP, and that there is no relationship between the peak ANP level and the heart rate in supraventricular tachycardia. They have concluded that the primary stimulus for release of ANP during supraventricular tachycardia is not an increase in heart rate per se, but a rise in right atrial pressure due to simultaneous contraction of the atrium and the ventricle with the tricuspid valve closed.
Increasing atrial pressure in rats through intravenous infusion of saline solution3) or intraatrial balloon dilatation4) increases the circulating level of ANP. We15) and others2) have reported that plasma ANP levels are highly correlated with mean PAWP in patients with cardiac impairment. Since PAWP reflects left atrial pressure, it appears that plasma ANP alters in proportion to left atrial pressure in cardiac patients.
It has been demonstrated that the mean PAWP and left ventricular filling pressure increase during exercise in both normal persons and patients with coronary artery disease.16), 17) The elevation of PAWP is reported to be increased in patients with coronary artery disease as compared with normal persons.18) The mechanism of the increase in left ventricular filling pressure during exercise-induced angina is still controversial. Angiographic studies during exercise-induced angina have revealed increased end-diastolic volume,19) whereas reduced myocardial compliance may play a role when ischemia is produced by cardiac pacing.20), 21) Regardless of the mechanism for the increase in left ventricular filling pressure during exercise-induced myocardial ischemia, the elevation in left ventricular filling pressure implies impaired left ventricular function in these patients and contributes to the increase in PAWP and circulating ANP. The present study has shown that there is a significant negative correlation between plasma ANP and ejection fraction only during exercise.
Ejection fraction was decreased after supine ergometer exercise in 5 patients with coronary artery disease, but increased in all normal volunteers. Because of the heterogeneous nature of coronary artery disease, a direct correlation between the anatomic extent of disease and the functional impairment of the ventricle during exercise could not be anticipated.8) The patient's age, sex, level of exercise conditioning, previous cardiac medications, level of excitement, level of stenosis, caliber of patent vessels and amount of collateral flow are some of the many factors that might influence the response of the left ventricle during exercise stress.22) Because plasma ANP may reflect atrial pressure or ventricular filling pressure, the estimation of plasma ANP during a standardized ergometer test may contribute to the evaluation of cardiac reserve in patients with coronary artery disease.
In conclusion, we have demonstrated that supine ergometer exercise testing raises the circulating levels of ANP in patients with coronary artery disease. The exercise-induced rise in plasma ANP is increased in patients with coronary artery disease as compared with normal persons. Plasma ANP is inversely and significantly correlated with ejection fraction only during exercise. It is suggested that the estimation of plasma ANP during an exercise stress test may be used for the evaluation of cardiac reserve in patients with coronary artery disease.
